Management of Indeterminate Thyroid Nodules Across Different World Regions
NCT ID: NCT05851404
Last Updated: 2023-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10000 participants
OBSERVATIONAL
2023-04-25
2023-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We aim to evaluate different approaches to indeterminate nodules across different countries in the world.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic and Prognostic Significance of Computerized Cytologic Morphometry of the Thyroid Neoplasm
NCT03105648
Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid
NCT04274829
Accuracy of FNAC in Thyroid Nodules Compared to to Surgical Specimen : QOC Experience
NCT05521594
Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma
NCT02648399
Assessment the Cancer Risk of Indeterminate Thyroid Nodules Through Integration of Clinical, Ultrasonographic and Multiomic Features
NCT05428371
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
South East Asian Region (SEAR)
Patients that underwent thyroidectomy for indeterminate thyroid nodules in the SEAR
Thyroidectomy
Total thyroidectomy or lobectomy
Americas Region (AMR)
Patients that underwent thyroidectomy for indeterminate thyroid nodules in the AMR
Thyroidectomy
Total thyroidectomy or lobectomy
Eastern Mediterranean Region (EMR)
Patients that underwent thyroidectomy for indeterminate thyroid nodules in the EMR
Thyroidectomy
Total thyroidectomy or lobectomy
the Europe Region (EUR)
Patients that underwent thyroidectomy for indeterminate thyroid nodules in the EUR
Thyroidectomy
Total thyroidectomy or lobectomy
Western Pacific Region (WPR)
Patients that underwent thyroidectomy for indeterminate thyroid nodules in the WPR
Thyroidectomy
Total thyroidectomy or lobectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thyroidectomy
Total thyroidectomy or lobectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Cagliari
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fabio Medas
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AOU Cagliari
Cagliari, CA, Italy
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UNICA-MEDAS-23-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.